La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Nova Eye Medical Performance dei guadagni passati
Il passato criteri di controllo 0/6
Nova Eye Medical's earnings have been declining at an average annual rate of -16.8%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 17.3% per year.
Informazioni chiave
-16.8%
Tasso di crescita degli utili
-13.7%
Tasso di crescita dell'EPS
| Medical Equipment Crescita del settore | 5.8% |
| Tasso di crescita dei ricavi | -17.3% |
| Rendimento del capitale proprio | -84.1% |
| Margine netto | -76.2% |
| Ultimo aggiornamento sui guadagni | 31 Dec 2023 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)
Aug 06
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward
Apr 18Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?
Mar 26News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts
Jan 19Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce
Dec 27We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate
Sep 03Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified
Apr 17Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?
Dec 16We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully
Aug 27Ripartizione dei ricavi e delle spese
Come Nova Eye Medical guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Dec 23 | 19 | -14 | 22 | 0 |
| 30 Sep 23 | 18 | -15 | 22 | 0 |
| 30 Jun 23 | 17 | -15 | 22 | 0 |
| 31 Mar 23 | 16 | -13 | 21 | 0 |
| 31 Dec 22 | 15 | -11 | 21 | 0 |
| 30 Sep 22 | 14 | -9 | 19 | 0 |
| 30 Jun 22 | 13 | -7 | 17 | 0 |
| 31 Mar 22 | 13 | -7 | 16 | 0 |
| 31 Dec 21 | 13 | -6 | 15 | 0 |
| 30 Sep 21 | 13 | -5 | 14 | 0 |
| 30 Jun 21 | 13 | -4 | 13 | 0 |
| 31 Dec 20 | 12 | -9 | 12 | 0 |
| 30 Sep 20 | 13 | -10 | 13 | 0 |
| 30 Jun 20 | 13 | -10 | 14 | 0 |
| 31 Dec 19 | 16 | -6 | 16 | 0 |
| 30 Sep 19 | 16 | -6 | 17 | 0 |
| 30 Jun 19 | 16 | -7 | 18 | 0 |
| 31 Mar 19 | 48 | -7 | 34 | 1 |
| 31 Dec 18 | 49 | -6 | 34 | 1 |
| 30 Sep 18 | 64 | -6 | 37 | 1 |
| 30 Jun 18 | 79 | -5 | 41 | 1 |
| 31 Mar 18 | 77 | -5 | 36 | 1 |
| 31 Dec 17 | 75 | -5 | 32 | 1 |
| 30 Sep 17 | 73 | -3 | 31 | 1 |
| 30 Jun 17 | 72 | -1 | 29 | 1 |
| 31 Mar 17 | 72 | 1 | 28 | 1 |
| 31 Dec 16 | 73 | 3 | 27 | 1 |
| 30 Sep 16 | 73 | 3 | 26 | 1 |
| 30 Jun 16 | 73 | 3 | 26 | 1 |
| 31 Mar 16 | 70 | 3 | 24 | 1 |
| 31 Dec 15 | 67 | 2 | 22 | 1 |
| 30 Sep 15 | 65 | 2 | 22 | 1 |
| 30 Jun 15 | 63 | 2 | 21 | 1 |
| 31 Mar 15 | 61 | 1 | 20 | 1 |
| 31 Dec 14 | 59 | 1 | 19 | 1 |
| 30 Sep 14 | 57 | 1 | 18 | 1 |
| 30 Jun 14 | 54 | 1 | 17 | 1 |
| 31 Mar 14 | 51 | 0 | 16 | 1 |
| 31 Dec 13 | 47 | -1 | 15 | 1 |
| 30 Sep 13 | 45 | -1 | 15 | 1 |
Guadagni di qualità: EYE is currently unprofitable.
Margine di profitto in crescita: EYE is currently unprofitable.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: EYE is unprofitable, and losses have increased over the past 5 years at a rate of 16.8% per year.
Accelerare la crescita: Unable to compare EYE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Guadagni vs Settore: EYE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendimento del capitale proprio
ROE elevato: EYE has a negative Return on Equity (-84.09%), as it is currently unprofitable.